Progesterone attenuates the effect of the 5-HT1A receptor agonist, 8-OH-DPAT, and of mild restraint on lordosis behavior

William Truitt, Lance Harrison, Jutatip Guptarak, Stacy White, Cindy Hiegel, Lynda Uphouse

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Ovariectomized, hormone-primed rats were used to test the hypothesis that progesterone treatment attenuated the effects of the 5-HT1A receptor agonist, (±)-8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT), on female rat lordosis behavior. Based upon prior evidence that prepriming with estradiol benzoate (EB) reduced the ability of 8-OH-DPAT to inhibit lordosis behavior, rats were preprimed with 10 μg EB 7 days before a second priming with 10 μg EB followed 48 h later with 500 μg progesterone or vehicle. Independent of the presence of progesterone, prepriming with EB attenuated the lordosis-inhibiting effects of systemic treatment with 8-OH-DPAT. However, progesterone also reduced the effects of 8-OH-DPAT and this effect was also seen in females primed only once with EB. In contrast, progesterone was relatively ineffective in attenuating the effects of bilateral infusion with 8-OH-DPAT into the ventromedial nucleus of the hypothalamus (VMN). The failure of progesterone to substantially reduce the effects of VMN infusion with 8-OH-DPAT contrasts with prior studies in which estrogen's protective action against the drug did include the VMN. Thus, while both estrogen and progesterone reduce the lordosis-inhibiting effect of 8-OH-DPAT, the mechanisms responsible for the effects of the two gonadal hormones may be different. Priming with progesterone also prevented the effects of 5 min of restraint. When rats were hormonally primed with EB and oil, rats showed a transient, but significant, decline in lordosis behavior 5 and 10 min after restraint. Rats primed with EB and progesterone were unaffected by the restraint. These results are discussed in terms of their implications for the role of progesterone in altering the 5-HT1A receptor modulation of lordosis behavior.

Original languageEnglish (US)
Pages (from-to)202-211
Number of pages10
JournalBrain Research
Volume974
Issue number1-2
DOIs
StatePublished - Jun 6 2003
Externally publishedYes

Fingerprint

Serotonin 5-HT1 Receptor Agonists
8-Hydroxy-2-(di-n-propylamino)tetralin
Lordosis
Receptor, Serotonin, 5-HT1A
Progesterone
Hypothalamus
Estrogens
Gonadal Hormones
hydroxide ion
Aptitude
estradiol 3-benzoate
Oils
Hormones

Keywords

  • 8-OH-DPAT
  • Estrogen
  • Female
  • Lordosis behavior
  • Progesterone
  • Restraint
  • Serotonin
  • Sexual behavior
  • Steroid

ASJC Scopus subject areas

  • Neuroscience(all)
  • Molecular Biology
  • Clinical Neurology
  • Developmental Biology

Cite this

Progesterone attenuates the effect of the 5-HT1A receptor agonist, 8-OH-DPAT, and of mild restraint on lordosis behavior. / Truitt, William; Harrison, Lance; Guptarak, Jutatip; White, Stacy; Hiegel, Cindy; Uphouse, Lynda.

In: Brain Research, Vol. 974, No. 1-2, 06.06.2003, p. 202-211.

Research output: Contribution to journalArticle

Truitt, William ; Harrison, Lance ; Guptarak, Jutatip ; White, Stacy ; Hiegel, Cindy ; Uphouse, Lynda. / Progesterone attenuates the effect of the 5-HT1A receptor agonist, 8-OH-DPAT, and of mild restraint on lordosis behavior. In: Brain Research. 2003 ; Vol. 974, No. 1-2. pp. 202-211.
@article{a360287e76c64d0dbbad73eb38db72c9,
title = "Progesterone attenuates the effect of the 5-HT1A receptor agonist, 8-OH-DPAT, and of mild restraint on lordosis behavior",
abstract = "Ovariectomized, hormone-primed rats were used to test the hypothesis that progesterone treatment attenuated the effects of the 5-HT1A receptor agonist, (±)-8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT), on female rat lordosis behavior. Based upon prior evidence that prepriming with estradiol benzoate (EB) reduced the ability of 8-OH-DPAT to inhibit lordosis behavior, rats were preprimed with 10 μg EB 7 days before a second priming with 10 μg EB followed 48 h later with 500 μg progesterone or vehicle. Independent of the presence of progesterone, prepriming with EB attenuated the lordosis-inhibiting effects of systemic treatment with 8-OH-DPAT. However, progesterone also reduced the effects of 8-OH-DPAT and this effect was also seen in females primed only once with EB. In contrast, progesterone was relatively ineffective in attenuating the effects of bilateral infusion with 8-OH-DPAT into the ventromedial nucleus of the hypothalamus (VMN). The failure of progesterone to substantially reduce the effects of VMN infusion with 8-OH-DPAT contrasts with prior studies in which estrogen's protective action against the drug did include the VMN. Thus, while both estrogen and progesterone reduce the lordosis-inhibiting effect of 8-OH-DPAT, the mechanisms responsible for the effects of the two gonadal hormones may be different. Priming with progesterone also prevented the effects of 5 min of restraint. When rats were hormonally primed with EB and oil, rats showed a transient, but significant, decline in lordosis behavior 5 and 10 min after restraint. Rats primed with EB and progesterone were unaffected by the restraint. These results are discussed in terms of their implications for the role of progesterone in altering the 5-HT1A receptor modulation of lordosis behavior.",
keywords = "8-OH-DPAT, Estrogen, Female, Lordosis behavior, Progesterone, Restraint, Serotonin, Sexual behavior, Steroid",
author = "William Truitt and Lance Harrison and Jutatip Guptarak and Stacy White and Cindy Hiegel and Lynda Uphouse",
year = "2003",
month = "6",
day = "6",
doi = "10.1016/S0006-8993(03)02581-2",
language = "English (US)",
volume = "974",
pages = "202--211",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Progesterone attenuates the effect of the 5-HT1A receptor agonist, 8-OH-DPAT, and of mild restraint on lordosis behavior

AU - Truitt, William

AU - Harrison, Lance

AU - Guptarak, Jutatip

AU - White, Stacy

AU - Hiegel, Cindy

AU - Uphouse, Lynda

PY - 2003/6/6

Y1 - 2003/6/6

N2 - Ovariectomized, hormone-primed rats were used to test the hypothesis that progesterone treatment attenuated the effects of the 5-HT1A receptor agonist, (±)-8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT), on female rat lordosis behavior. Based upon prior evidence that prepriming with estradiol benzoate (EB) reduced the ability of 8-OH-DPAT to inhibit lordosis behavior, rats were preprimed with 10 μg EB 7 days before a second priming with 10 μg EB followed 48 h later with 500 μg progesterone or vehicle. Independent of the presence of progesterone, prepriming with EB attenuated the lordosis-inhibiting effects of systemic treatment with 8-OH-DPAT. However, progesterone also reduced the effects of 8-OH-DPAT and this effect was also seen in females primed only once with EB. In contrast, progesterone was relatively ineffective in attenuating the effects of bilateral infusion with 8-OH-DPAT into the ventromedial nucleus of the hypothalamus (VMN). The failure of progesterone to substantially reduce the effects of VMN infusion with 8-OH-DPAT contrasts with prior studies in which estrogen's protective action against the drug did include the VMN. Thus, while both estrogen and progesterone reduce the lordosis-inhibiting effect of 8-OH-DPAT, the mechanisms responsible for the effects of the two gonadal hormones may be different. Priming with progesterone also prevented the effects of 5 min of restraint. When rats were hormonally primed with EB and oil, rats showed a transient, but significant, decline in lordosis behavior 5 and 10 min after restraint. Rats primed with EB and progesterone were unaffected by the restraint. These results are discussed in terms of their implications for the role of progesterone in altering the 5-HT1A receptor modulation of lordosis behavior.

AB - Ovariectomized, hormone-primed rats were used to test the hypothesis that progesterone treatment attenuated the effects of the 5-HT1A receptor agonist, (±)-8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT), on female rat lordosis behavior. Based upon prior evidence that prepriming with estradiol benzoate (EB) reduced the ability of 8-OH-DPAT to inhibit lordosis behavior, rats were preprimed with 10 μg EB 7 days before a second priming with 10 μg EB followed 48 h later with 500 μg progesterone or vehicle. Independent of the presence of progesterone, prepriming with EB attenuated the lordosis-inhibiting effects of systemic treatment with 8-OH-DPAT. However, progesterone also reduced the effects of 8-OH-DPAT and this effect was also seen in females primed only once with EB. In contrast, progesterone was relatively ineffective in attenuating the effects of bilateral infusion with 8-OH-DPAT into the ventromedial nucleus of the hypothalamus (VMN). The failure of progesterone to substantially reduce the effects of VMN infusion with 8-OH-DPAT contrasts with prior studies in which estrogen's protective action against the drug did include the VMN. Thus, while both estrogen and progesterone reduce the lordosis-inhibiting effect of 8-OH-DPAT, the mechanisms responsible for the effects of the two gonadal hormones may be different. Priming with progesterone also prevented the effects of 5 min of restraint. When rats were hormonally primed with EB and oil, rats showed a transient, but significant, decline in lordosis behavior 5 and 10 min after restraint. Rats primed with EB and progesterone were unaffected by the restraint. These results are discussed in terms of their implications for the role of progesterone in altering the 5-HT1A receptor modulation of lordosis behavior.

KW - 8-OH-DPAT

KW - Estrogen

KW - Female

KW - Lordosis behavior

KW - Progesterone

KW - Restraint

KW - Serotonin

KW - Sexual behavior

KW - Steroid

UR - http://www.scopus.com/inward/record.url?scp=0037988841&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037988841&partnerID=8YFLogxK

U2 - 10.1016/S0006-8993(03)02581-2

DO - 10.1016/S0006-8993(03)02581-2

M3 - Article

VL - 974

SP - 202

EP - 211

JO - Brain Research

JF - Brain Research

SN - 0006-8993

IS - 1-2

ER -